covid vaccine | sciencenewsnet.in

COVID Vaccine: Focus on Distribution Speed Over Allocation Prioritization, says Supply Chain Systems Expert

January 13, 2021 sarah Jonas covid vaccine, Robert H. Smith School Of Business, Supply Chain Management, systems research, University Of Maryland, vaccine distribution

University of Maryland Professor Emeritus Michael O. Ball, a researcher and expert on supply chain management and system reliability, is

Feature

LifeBridge Health Begins COVID-19 Vaccinations of Front-line Caregivers

December 18, 2020 sarah Jonas coronavirus vaccine, covid, covid vaccine, front-line workers, Lifebridge Health, Northwest Hospital, pfizer vaccine

LifeBridge Health has begun to administer the COVID-19 vaccine to front-line healthcare workers. The first doses of the newly approved Pfizer COVID vaccine arrived at LifeBridge Health on December 17 with 24 team members receiving the vaccine that afternoon at Sinai Hospital.

Research Results

American College of Allergy, Asthma, and Immunology Releases Guidance on Risk of Allergic Reactions to the Pfizer-BioNTech COVID-19 Vaccine

December 14, 2020 sarah Jonas Acaai, Allergists, covid vaccine

With the emergency use authorization of the Pfizer-BioNTech COVID-19 vaccine by the FDA on December 11, 2020, and distribution beginning today, the American College of Allergy, Asthma and Immunology COVID-19 Vaccine Task Force recommends the following guidance related to risk of an allergic reaction on vaccination for those who receive the vaccine.

Research Results

Over half of adults over 50 say they’ll get vaccinated against COVID-19, but many will want to wait, poll finds

November 24, 2020 sarah Jonas Coronavirus, covid vaccine, COVID-19, Health Communication, Older Adults, Vaccination, Vaccine

A new poll of adults ages 50 to 80 suggests that achieving the widespread vaccination against COVID-19 needed to protect this high-risk group and end the pandemic will be an uphill climb, and require clear, transparent communication from health providers and others.

Announcement

What We Know: Mount Sinai to Host COVID-19 Research Symposium

November 12, 2020 sarah Jonas Artificial Intelligence, Coronavirus, covid, covid vaccine, COVID-19, Genomics, Icahn School of Medicine at Mount Sinai, Immunology, Mount Sinai Health System, Vaccine

The COVID-19 Research Symposium, hosted by the Mount Sinai Clinical Intelligence Center (MSCIC), is a one-day comprehensive review of advances in research by the Mount Sinai Health System to better understand and treat the coronavirus known as COVID-19.

Expert Pitch

Rutgers Expert Available to Discuss Pfizer’s Vaccine

November 11, 2020 sarah Jonas Coronavirus, covid vaccine, COVID-19, COVID-19 Vaccine, Pfizer

A Rutgers public health expert is available to discuss Pfizer’s vaccine, which has shown to be effective according to recent

Announcement

New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test

September 17, 2020 sarah Jonas antibody testing, Carlos Cordon-Cardo, covid vaccine, covid-19 immunity, Elisa, Florian Krammer, Icahn School of Medicine at Mount Sinai, Mount Sinai Health System, quantitative antibody test, SARS-CoV-2, SARS-CoV-2 antibodies, SARS-CoV-2 virus, serological COVID-19 tests

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood

Announcement

UH Selected as Clinical Trial Site to Test Pfizer and BioNTech’s COVID-19 Vaccine

August 24, 2020 sarah Jonas covid vaccine, COVID-19, SARS-CoV-2

Announcement of University Hospitals plans to participate as a site for the Phase 2/3 global study sponsored by Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) of an investigational vaccine, BNT162b2, against SARS-CoV-2.

Research Alert

Mount Sinai study finds SARS-CoV-2 induces robust antibody responses stable for at least 3 months

July 20, 2020 sarah Jonas covid vaccine, COVID-19, COVID-19 antibodies, Elisa, Florian Krammer, Icahn School of Medicine at Mount Sinai, Mount Sinai, Mount Sinai Health System, Mount Sinai Hospital, SARS-CoV-2, SARS-CoV-2 antibodies, Serological assay, serological COVID-19 tests, Serological tests

Research from the Mount Sinai Health System, just posted to pre-print server MedRxiv (https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1), shows that the vast majority (more than

Expert Pitch

Expert available to speak about legal response to fraudulent COVID-19 cures and treatments

May 14, 2020 sarah Jonas Coronavirus Disease, coronavirus response, covid 19, COVID Treatment, covid vaccine

By: Mark Blackwell Thomas | Published: May 14, 2020 | 12:36 pm | SHARE: As the number of COVID-19 cases in the U.S. continues to increase, one Florida State University researcher said the number of people looking to profit from the misfortune by offering false, unproven cures is also on the rise. There is no known cure for COVID-19 but Chad Marzen, associate professor of law in the FSU College of Business, said that hasn’t stopped opportunists from looking to capitalize off people’s fears.